Advertisement
Screener

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$528.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-29

  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$528.00M, a 200.19% decline year-over-year.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $248.00M, a 65.56% decline year-over-year.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $565.00M.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $390.00M.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $2.20B.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$2.47B.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$524.00M.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$2.77B, a 4360.00% decline from fiscal 2021.
Period endComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30-$528.00M
10-Q · filed 2026-07-29
-$280.00M
10-Q · filed 2026-07-29
$285.00M
derived: sum of 3 quarters · filed 2026-07-29
$675.00M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$248.00M
10-Q · filed 2026-04-29
$813.00M
derived: sum of 2 quarters · filed 2026-04-29
$1.20B
derived: sum of 3 quarters · filed 2026-04-29
$1.73B
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$565.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
$955.00M
derived: sum of 2 quarters · filed 2026-02-03
$1.48B
derived: sum of 3 quarters · filed 2026-07-29
$2.20B
10-K · filed 2026-02-03
2025-09-30$390.00M
10-Q · filed 2025-11-05
$917.00M
derived: sum of 2 quarters · filed 2026-07-29
$1.64B
10-Q · filed 2025-11-05
$929.00M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$527.00M
10-Q · filed 2026-07-29
$1.25B
10-Q · filed 2026-07-29
$539.00M
derived: sum of 3 quarters · filed 2026-07-29
$329.00M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$720.00M
10-Q · filed 2026-04-29
$12.00M
derived: sum of 2 quarters · filed 2026-04-29
-$198.00M
derived: sum of 3 quarters · filed 2026-04-29
-$1.21B
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31-$708.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
-$918.00M
derived: sum of 2 quarters · filed 2026-02-03
-$1.93B
derived: sum of 3 quarters · filed 2026-02-03
-$2.47B
10-K · filed 2026-02-03
2024-09-30-$210.00M
10-Q · filed 2025-11-05
-$1.22B
derived: sum of 2 quarters · filed 2025-11-05
-$1.76B
10-Q · filed 2025-11-05
-$1.04B
derived: sum of 4 quarters · filed 2026-02-03
2024-06-30-$1.01B
10-Q · filed 2025-07-30
-$1.55B
10-Q · filed 2025-07-30
-$834.00M
derived: sum of 3 quarters · filed 2026-02-03
-$1.01B
derived: sum of 4 quarters · filed 2026-02-03
2024-03-31-$536.00M
10-Q · filed 2025-05-07
$178.00M
derived: sum of 2 quarters · filed 2026-02-03
$6.00M
derived: sum of 3 quarters · filed 2026-02-03
-$935.00M
derived: sum of 4 quarters · filed 2026-02-03
2023-12-31$714.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
$542.00M
derived: sum of 2 quarters · filed 2026-02-03
-$399.00M
derived: sum of 3 quarters · filed 2026-02-03
-$524.00M
10-K · filed 2026-02-03
2023-09-30-$172.00M
10-Q · filed 2024-11-06
-$161.00M
10-Q · filed 2023-11-09
-$1.11B
derived: sum of 2 quarters · filed 2024-11-06
-$1.24B
10-Q · filed 2024-11-06
-$1.20B
10-Q · filed 2023-11-09
-$2.19B
derived: sum of 4 quarters · filed 2025-02-05
2023-06-30-$941.00M
10-Q · filed 2024-07-31
-$933.00M
10-Q · filed 2023-08-02
-$1.07B
10-Q · filed 2024-07-31
-$1.04B
10-Q · filed 2023-08-02
-$2.02B
derived: sum of 3 quarters · filed 2025-02-05
-$2.36B
derived: sum of 4 quarters · filed 2025-02-05
2023-03-31-$126.00M
10-Q · filed 2024-05-08
-$111.00M
10-Q · filed 2023-05-10
-$1.08B
derived: sum of 2 quarters · filed 2025-02-05
-$1.42B
derived: sum of 3 quarters · filed 2025-02-05
-$1.89B
derived: sum of 4 quarters · filed 2025-02-05
2022-12-31-$954.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05
-$1.29B
derived: sum of 2 quarters · filed 2025-02-05
-$1.76B
derived: sum of 3 quarters · filed 2025-02-05
-$2.77B
10-K · filed 2025-02-05
-$2.68B
10-K · filed 2023-02-10
2022-09-30-$337.00M
10-Q · filed 2023-11-09
-$808.00M
derived: sum of 2 quarters · filed 2023-11-09
-$1.81B
10-Q · filed 2023-11-09
-$2.06B
derived: sum of 4 quarters · filed 2024-02-12
2022-06-30-$471.00M
10-Q · filed 2023-08-02
-$1.48B
10-Q · filed 2023-08-02
-$1.72B
derived: sum of 3 quarters · filed 2024-02-12
-$1.61B
derived: sum of 4 quarters · filed 2024-02-12
2022-03-31-$1.01B
10-Q · filed 2023-05-10
-$1.25B
derived: sum of 2 quarters · filed 2024-02-12
-$1.14B
derived: sum of 3 quarters · filed 2024-02-12
-$827.00M
derived: sum of 4 quarters · filed 2024-02-12
2021-12-31-$241.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12
-$126.00M
derived: sum of 2 quarters · filed 2024-02-12
$182.00M
derived: sum of 3 quarters · filed 2024-02-12
$65.00M
10-K · filed 2024-02-12
2021-09-30$115.00M
10-Q · filed 2022-11-03
$423.00M
derived: sum of 2 quarters · filed 2022-11-03
$306.00M
10-Q · filed 2022-11-03
$740.00M
derived: sum of 4 quarters · filed 2023-02-10
2021-06-30$308.00M
10-Q · filed 2022-07-27
$191.00M
10-Q · filed 2022-07-27
$625.00M
derived: sum of 3 quarters · filed 2023-02-10
-$3.64B
derived: sum of 4 quarters · filed 2023-02-10
2021-03-31-$117.00M
10-Q · filed 2022-05-03
$317.00M
derived: sum of 2 quarters · filed 2023-02-10
-$3.94B
derived: sum of 3 quarters · filed 2023-02-10
-$3.74B
derived: sum of 4 quarters · filed 2023-02-10
2020-12-31$434.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10
-$3.83B
derived: sum of 2 quarters · filed 2023-02-10
-$3.62B
derived: sum of 3 quarters · filed 2023-02-10
-$4.13B
10-K · filed 2023-02-10
2020-09-30-$4.26B
10-Q · filed 2021-10-27
-$4.06B
derived: sum of 2 quarters · filed 2021-10-27
-$4.56B
10-Q · filed 2021-10-27
-$4.44B
derived: sum of 4 quarters · filed 2022-02-09
2020-06-30$204.00M
10-Q · filed 2021-07-28
-$301.00M
10-Q · filed 2021-07-28
-$182.00M
derived: sum of 3 quarters · filed 2022-02-09
-$542.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-03-31-$505.00M
10-Q · filed 2021-04-28
-$386.00M
derived: sum of 2 quarters · filed 2022-02-09
-$746.00M
derived: sum of 3 quarters · filed 2022-02-09
-$1.34B
derived: sum of 4 quarters · filed 2022-02-09
2019-12-31$119.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
-$241.00M
derived: sum of 2 quarters · filed 2022-02-09
-$836.00M
derived: sum of 3 quarters · filed 2022-02-09
-$840.00M
10-K · filed 2022-02-09
2019-09-30-$360.00M
10-Q · filed 2020-11-05
-$955.00M
derived: sum of 2 quarters · filed 2020-11-05
-$959.00M
10-Q · filed 2020-11-05
-$4.28B
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30-$595.00M
10-Q · filed 2020-08-05
-$598.00M
10-Q · filed 2020-08-05
-$3.92B
derived: sum of 3 quarters · filed 2021-02-10
-$4.21B
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31-$3.00M
10-Q · filed 2020-05-07
-$3.33B
derived: sum of 2 quarters · filed 2021-02-10
-$3.61B
derived: sum of 3 quarters · filed 2021-02-10
-$4.39B
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31-$3.33B
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10
-$3.61B
derived: sum of 2 quarters · filed 2021-02-10
-$4.39B
derived: sum of 3 quarters · filed 2021-02-10
-$3.06B
10-K · filed 2021-02-10
2018-09-30-$281.00M
10-Q · filed 2019-11-07
-$1.06B
derived: sum of 2 quarters · filed 2019-11-07
$269.00M
10-Q · filed 2019-11-07
-$11.12B
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30-$780.00M
10-Q · filed 2019-08-07
$550.00M
10-Q · filed 2019-08-07
-$10.84B
derived: sum of 3 quarters · filed 2020-02-21
-$10.03B
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$1.33B
10-Q · filed 2019-05-02
-$10.06B
derived: sum of 2 quarters · filed 2020-02-21
-$9.25B
derived: sum of 3 quarters · filed 2020-02-21
-$14.91B
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31-$11.39B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
-$10.58B
derived: sum of 2 quarters · filed 2020-02-21
-$16.24B
derived: sum of 3 quarters · filed 2020-02-21
-$15.08B
10-K · filed 2020-02-21
-$14.96B
10-K · filed 2018-02-12
2017-09-30$809.00M
10-Q · filed 2018-11-01
$798.00M
6-K · filed 2017-11-02
-$4.85B
derived: sum of 2 quarters · filed 2018-11-01
-$3.69B
10-Q · filed 2018-11-01
-$3.77B
6-K · filed 2017-11-02
-$5.12B
derived: sum of 4 quarters · filed 2018-11-01
2017-06-30-$5.66B
10-Q · filed 2018-08-02
-$5.66B
6-K · filed 2017-08-03
-$4.50B
10-Q · filed 2018-08-02
-$4.57B
6-K · filed 2017-08-03
-$5.93B
derived: sum of 3 quarters · filed 2018-08-02
-$5.68B
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$1.16B
10-Q · filed 2018-05-03
$1.09B
6-K · filed 2017-05-11
-$270.00M
derived: sum of 2 quarters · filed 2018-05-03
-$20.00M
derived: sum of 3 quarters · filed 2018-05-03
-$74.00M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31-$1.43B
derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12
-$1.18B
derived: sum of 2 quarters · filed 2018-02-12
-$1.23B
derived: sum of 3 quarters · filed 2018-02-12
-$953.00M
10-K · filed 2019-02-19
2016-09-30$250.00M
6-K · filed 2017-11-02
$196.00M
derived: sum of 2 quarters · filed 2017-11-02
$551.00M
6-K · filed 2017-11-02
$1.24B
derived: sum of 4 quarters · filed 2018-02-12
2016-06-30-$54.00M
6-K · filed 2017-08-03
$301.00M
6-K · filed 2017-08-03
$987.00M
derived: sum of 3 quarters · filed 2018-02-12
$841.00M
derived: sum of 4 quarters · filed 2018-02-12
2016-03-31$355.00M
6-K · filed 2017-05-11
$1.04B
derived: sum of 2 quarters · filed 2018-02-12
$895.00M
derived: sum of 3 quarters · filed 2018-02-12
$1.46B
derived: sum of 4 quarters · filed 2018-02-12
2015-12-31$686.00M
derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12
$540.00M
derived: sum of 2 quarters · filed 2018-02-12
$1.11B
derived: sum of 3 quarters · filed 2018-02-12
$976.00M
10-K · filed 2018-02-12
2015-09-30-$146.00M
6-K · filed 2016-11-15
$423.00M
derived: sum of 2 quarters · filed 2016-11-15
$290.00M
6-K · filed 2016-11-15
$470.00M
derived: sum of 4 quarters · filed 2017-02-15
2015-06-30$569.00M
6-K · filed 2016-08-04
$436.00M
6-K · filed 2016-08-04
$616.00M
derived: sum of 3 quarters · filed 2017-02-15
$912.00M
derived: sum of 4 quarters · filed 2017-02-15
2015-03-31-$133.00M
6-K · filed 2016-05-09
$47.00M
derived: sum of 2 quarters · filed 2017-02-15
$343.00M
derived: sum of 3 quarters · filed 2017-02-15
$1.08B
derived: sum of 4 quarters · filed 2017-02-15
2014-12-31$180.00M
derived: 20-F 12 month − 6-K 9 month · filed 2017-02-15
$476.00M
derived: sum of 2 quarters · filed 2017-02-15
$1.22B
derived: sum of 3 quarters · filed 2017-02-15
$1.80B
20-F · filed 2017-02-15
2014-09-30$296.00M
6-K · filed 2015-10-29
$1.04B
derived: sum of 2 quarters · filed 2015-10-29
$1.62B
6-K · filed 2015-10-29
$2.07B
derived: sum of 4 quarters · filed 2016-02-11
2014-06-30$740.00M
6-K · filed 2015-07-30
$1.33B
6-K · filed 2015-07-30
$1.77B
derived: sum of 3 quarters · filed 2016-02-11
$2.78B
derived: sum of 4 quarters · filed 2016-02-11
2014-03-31$587.00M
6-K · filed 2015-04-30
$1.03B
derived: sum of 2 quarters · filed 2016-02-11
$2.04B
derived: sum of 3 quarters · filed 2016-02-11
$1.39B
derived: sum of 4 quarters · filed 2016-02-11
2013-12-31$447.00M
derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11
$1.45B
derived: sum of 2 quarters · filed 2016-02-11
$799.00M
derived: sum of 3 quarters · filed 2016-02-11
$1.20B
20-F · filed 2016-02-11
2013-09-30$1.01B
6-K · filed 2014-10-30
$352.00M
derived: sum of 2 quarters · filed 2014-10-30
$748.00M
6-K · filed 2014-10-30
$1.28B
derived: sum of 4 quarters · filed 2015-02-09
2013-06-30-$655.00M
6-K · filed 2014-07-31
-$259.00M
6-K · filed 2014-07-31
$277.00M
derived: sum of 3 quarters · filed 2015-02-09
$649.00M
derived: sum of 4 quarters · filed 2015-02-09
2013-03-31$396.00M
6-K · filed 2014-05-02
$932.00M
derived: sum of 2 quarters · filed 2015-02-09
$1.30B
derived: sum of 3 quarters · filed 2015-02-09
$1.34B
derived: sum of 4 quarters · filed 2015-02-09
2012-12-31$536.00M
derived: 20-F 12 month − 6-K 9 month · filed 2015-02-09
$908.00M
derived: sum of 2 quarters · filed 2015-02-09
$945.00M
derived: sum of 3 quarters · filed 2015-02-09
$2.54B
20-F · filed 2015-02-09
2012-09-30$372.00M
6-K · filed 2013-10-31
$409.00M
derived: sum of 2 quarters · filed 2013-10-31
$2.00B
6-K · filed 2013-10-31
$1.63B
derived: sum of 4 quarters · filed 2014-02-10
2012-06-30$37.00M
6-K · filed 2013-08-01
$1.63B
6-K · filed 2013-08-01
$1.26B
derived: sum of 3 quarters · filed 2014-02-10
$904.00M
derived: sum of 4 quarters · filed 2014-02-10
2012-03-31$1.59B
6-K · filed 2013-05-02
$1.22B
derived: sum of 2 quarters · filed 2014-02-10
$867.00M
derived: sum of 3 quarters · filed 2014-02-10
$1.74B
derived: sum of 4 quarters · filed 2014-02-10
2011-12-31-$369.00M
derived: 20-F 12 month − 6-K 9 month · filed 2014-02-10
-$723.00M
derived: sum of 2 quarters · filed 2014-02-10
$148.00M
derived: sum of 3 quarters · filed 2014-02-10
$1.82B
20-F · filed 2014-02-10
$1.83B
20-F · filed 2012-02-17
2011-09-30-$354.00M
6-K · filed 2012-11-01
$517.00M
derived: sum of 2 quarters · filed 2012-11-01
$2.19B
6-K · filed 2012-11-01
$2.67B
derived: sum of 4 quarters · filed 2013-02-12
2011-06-30$871.00M
6-K · filed 2012-08-02
$2.54B
6-K · filed 2012-08-02
$3.03B
derived: sum of 3 quarters · filed 2013-02-12
$5.49B
derived: sum of 4 quarters · filed 2013-02-12
2011-03-31$1.67B
6-K · filed 2012-05-09
$2.15B
derived: sum of 2 quarters · filed 2013-02-12
$4.62B
derived: sum of 3 quarters · filed 2013-02-12
$4.36B
derived: sum of 4 quarters · filed 2013-02-12
2010-12-31$482.00M
derived: 20-F 12 month − 6-K 9 month · filed 2013-02-12
$2.95B
derived: sum of 2 quarters · filed 2013-02-12
$2.69B
derived: sum of 3 quarters · filed 2013-02-12
$3.13B
20-F · filed 2013-02-12
$3.13B
20-F · filed 2011-02-15
2010-09-30$2.47B
6-K · filed 2011-11-02
$2.21B
derived: sum of 2 quarters · filed 2011-11-02
$2.64B
6-K · filed 2011-11-02
2010-06-30-$262.00M
6-K · filed 2011-07-28
$176.00M
6-K · filed 2011-07-28
2010-03-31$438.00M
6-K · filed 2011-05-11
2009-12-31$2.17B
20-F · filed 2012-02-17
2008-12-31-$360.00M
20-F · filed 2011-02-15